HIV News and Research

RSS

Scientists develop synthetic molecule effective at kicking and killing HIV

Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly reduce the chance of transmission from person to person.

5 Oct 2017

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

A 30 year old Australian woman presented to the doctors with numerous small lumps under her arms for around two weeks. When one of the nodes were put under the microscope, the doctors found pigments from tattoo ink that she’d got 15 years back.

4 Oct 2017

Researchers identify new cancer-causing pathway behind most aggressive type of leukemia

A team led by Massachusetts General Hospital (MGH) investigators has identified a new cancer-causing pathway behind most cases of an aggressive type of leukemia, findings that could lead to new targeted treatment approaches.

3 Oct 2017

Gay and bisexual men with lower education, income have higher suicide risks

Gay and bisexual men making less than $30,000 a year and without a university degree have more than five times the odds of attempting suicide compared with their more advantaged peers, according to new research from the University of British Columbia.

3 Oct 2017

UTHealth study focuses on how gene-environment interactions impact cocaine use disorder

Studying the effect of environmental stressors on the development of cocaine use is the focus of a $2.6 million award from the National Institutes of Health to researchers at McGovern Medical School at The University of Texas Health Science Center at Houston.

3 Oct 2017

Achieving treatment targets of National HIV/AIDS Strategy would prevent new infections and deaths

An analysis led by a team of Massachusetts General Hospital investigators shows that achieving the treatment targets of the National HIV/AIDS Strategy by 2020 not only would prevent hundreds of thousands of new infections and deaths but also would demonstrate excellent value.

28 Sep 2017

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

27 Sep 2017

HIV cases on the rise among those in their 50s in Europe

A new study has found that one in every six persons diagnosed with HIV is over the age of 50 years. This new study was published yesterday (26th September 2017) in the journal Lancet HIV.

27 Sep 2017

CDC warns about steep rise in STDs among Americans

According to a statement from the Centers for Disease Control and Prevention yesterday (26th September 2017), in 2016, a survey has revealed that more than 2 million Americans have been diagnosed with a sexually transmitted disease (STD) including infections such as gonorrhea, syphilis and Chlamydia. This is one of the highest numbers that have been detected till date they say.

27 Sep 2017

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.

27 Sep 2017

Cellular messaging mechanism could lead to new way of treating disease

A newly discovered cellular messaging mechanism could lead to a new way to deliver therapeutics to tissues affected by disease, according to a new study from Harvard T.H. Chan School of Public Health.

27 Sep 2017

California scrambles to contain ‘unprecedented’ hepatitis A outbreaks

Health officials in California are struggling to contain fierce outbreaks of hepatitis A among homeless people and drug abusers in three counties, including San Diego, where at least 17 people have died.

26 Sep 2017

Researchers will measure and examine how ‘resilience’ may lead to better HIV-related outcomes

With studies showing that African Americans living with HIV disproportionately struggle to remain in care and maintain suppressed HIV RNA levels, a team of public health researchers will look for solutions in a new way: They will systematically and rigorously identify the resources that successful patients draw upon to overcome the pervasive pitfalls that hinder others.

26 Sep 2017

MIT study sheds light on flu viruses' rapid evolution

Influenza viruses mutate rapidly, which is why flu vaccines have to be redesigned every year. A new study from MIT sheds light on just how these viruses evolve so quickly and offers a potential way to slow them down.

26 Sep 2017

Drinking three or more cups of coffee a day linked to reduced mortality risk in HIV-HCV patients

Patients infected by both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are at specific risk of end-stage liver disease and greater risk of cardiovascular diseases and cancer.

25 Sep 2017

Study finds low screening rates for adolescents with PID in nation’s ED setting

The nation's emergency departments had low rates of complying with recommended HIV and syphilis screening for at-risk adolescents, though larger hospitals were more likely to provide such evidence-based care, according to a study presented during the 2017 American Academy of Pediatrics (AAP) national conference

22 Sep 2017

Triple-action antibody to be tested as HIV vaccine

Scientists from the National Institutes of Health (NIH) in collaboration with the pharmaceutical company Sanofi have engineered a three-pronged antibody that protected monkeys from two strains of Human Immunodeficiency Virus (HIV) better than the equivalent naturally occurring antibodies.

22 Sep 2017

New study shows how staph cells evade the body's immune system

For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the body's immune system, offering a clearer picture of how a successful vaccine would work.

21 Sep 2017

Routine and rapid HCV testing improves life expectancy, reduces costs for young adults

Routine and rapid hepatitis C virus testing among young adults who use injection drugs improves life expectancy and may provide a good use of limited resources, according to new research out of Boston Medical Center, in partnership with the Boston Public Health Commission.

21 Sep 2017

Study: Onset of adolescence triggers common, rigid gender expectations linked to lifelong risks

Whether you are child in Baltimore, Beijing, Nairobi or New Delhi, the onset of adolescence triggers a surprisingly common set of rigidly enforced gender expectations that are linked to increased lifelong risks of everything from HIV and depression to violence and suicide.

21 Sep 2017

HIV News and Research

Scientists develop synthetic molecule effective at kicking and killing HIV

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

Researchers identify new cancer-causing pathway behind most aggressive type of leukemia

Gay and bisexual men with lower education, income have higher suicide risks

UTHealth study focuses on how gene-environment interactions impact cocaine use disorder

Achieving treatment targets of National HIV/AIDS Strategy would prevent new infections and deaths

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

HIV cases on the rise among those in their 50s in Europe

CDC warns about steep rise in STDs among Americans

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Cellular messaging mechanism could lead to new way of treating disease

California scrambles to contain ‘unprecedented’ hepatitis A outbreaks

Researchers will measure and examine how ‘resilience’ may lead to better HIV-related outcomes

MIT study sheds light on flu viruses' rapid evolution

Drinking three or more cups of coffee a day linked to reduced mortality risk in HIV-HCV patients

Study finds low screening rates for adolescents with PID in nation’s ED setting

Triple-action antibody to be tested as HIV vaccine

New study shows how staph cells evade the body's immune system

Routine and rapid HCV testing improves life expectancy, reduces costs for young adults

Study: Onset of adolescence triggers common, rigid gender expectations linked to lifelong risks

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News